Omrix Biopharmaceuticals, Inc. 4
4 · Omrix Biopharmaceuticals, Inc. · Filed Jun 5, 2007
Insider Transaction Report
Form 4
PRICE FREDRIC D
Director
Transactions
- Exercise/Conversion
Stock Option
2007-06-04−49,000→ 60,091 totalExercise: $6.19From: 2004-12-17Exp: 2014-12-17→ Common Stock (49,000 underlying) - Sale
Common Stock
2007-06-04$33.80/sh−49,000$1,656,200→ 7,000 total - Exercise/Conversion
Common Stock
2007-06-04$6.19/sh+49,000$303,188→ 56,000 total